State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma

WT Garzon-Siatoya, I Carrillo-Martin… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Asthma, a heterogeneous disease, is characterized by chronic airway
inflammation and hyperreactivity. β2-adrenoreceptor agonists (β2-agonists) remain pivotal …
被引用次数：10 相关文章

State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma

WT Garzon-Siatoya, I Carrillo-Martin… - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Asthma, a heterogeneous disease, is characterized by chronic airway
inflammation and hyperreactivity. β 2-adrenoreceptor agonists (β 2-agonists) remain pivotal …

State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma.

WT Garzon-Siatoya, I Carrillo-Martin… - Expert Opinion on …, 2021 - europepmc.org
Asthma, a heterogeneous disease, is characterized by chronic airway inflammation and
hyperreactivity. β 2-adrenoreceptor agonists (β 2-agonists) remain pivotal for asthma …